Rossari Biotech Ltd.

NSE: ROSSARI | BSE: 543213 | ISIN: INE02A801020 | Industry: Specialty Chemicals
| Mid-range Performer
690.1000 5.20 (0.76%)
NSE Jun 05, 2025 13:19 PM
Volume: 30,240
 

690.10
0.76%
ICICI Securities Limited
Rossari Biotech’s (Rossari) Q2FY24 HPPC revenue (+21% YoY) was led by a volume push which has hurt prices and margins. Despite rise in utilisation from 50-55% to >75%, EBITDA margin dipped 100bp QoQ to 13.1%. It has chosen to play volume game for FY24 to drive utilisation, and expects to improve margins as plant utilisations stabilise at higher levels, which in our view can cap return ratio in near term.
Rossari Biotech Ltd. is trading above its 100 day SMA of 681.3
More from Rossari Biotech Ltd.
Recommended